Browse By: Country ι Category ι Tag
Home  »  Gastric Cancer

Gastric Cancer Market Research Reports

More

China Gastric Cancer Drug Market Research Report 2017
Sales, means the sales volume of Gastric Cancer Drug Revenue, means the sales value of Gastric Cancer Drug This report studies Gastric Cancer Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share an
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Europe Gastric Cancer Drug Market Report 2017
Sales, means the sales volume of Gastric Cancer Drug Revenue, means the sales value of Gastric Cancer Drug This report studies sales (consumption) of Gastric Cancer Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market s
Published Date: Feb 2017
Published By: QYResearch

Price: $3900
United States Gastric Cancer Drug Market Report 2017
Sales, means the sales volume of Gastric Cancer Drug Revenue, means the sales value of Gastric Cancer Drug This report studies sales (consumption) of Gastric Cancer Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by appli
Published Date: Feb 2017
Published By: QYResearch

Price: $3800
Global Gastric Cancer Drug Sales Market Report 2017
Sales, means the sales volume of Gastric Cancer Drug Revenue, means the sales value of Gastric Cancer Drug This report studies sales (consumption) of Gastric Cancer Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and grow
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Global Gastric Cancer Drug Market Research Report 2017
Production, means the output of Gastric Cancer Drug Revenue, means the sales value of Gastric Cancer Drug This report studies Gastric Cancer Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and g
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
Global Gastric Cancer Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation o
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Global Gastric Cancer Therapeutics Industry 2017, Trends and Forecast Report
The report firstly introduced the Gastric Cancer Therapeutics basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Gastric Cancer Therapeutics Market; 3.) the North American Gastric Cancer Therapeutics Market; 4.) the European Gastric Cancer Therapeutics Market; 5.) market entry and investment feasibili
Published Date: Jan 2017
Published By: 9Dimen Research

Price: $2850
Gastric Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gastric Ca
Published Date: Oct 2016
Published By: Global Markets Direct

Price: $2000
China Gastric Cancer Drugs Market Report 2016
Sales, means the sales volume of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies sales (consumption) of Gastric Cancer Drugs in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Gas
Published Date: Oct 2016
Published By: QYResearch

Price: $3200
Europe Gastric Cancer Drugs Market Report 2016
Sales, means the sales volume of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies sales (consumption) of Gastric Cancer Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Covidien llc (Medtronic) Johnson & Johnson MEDICAL Bolton Surgical Platts & Nisbett Frankenman International Changzhou Waston Jiangsu Qianjing Medical Changzhou Anker Medical Changzhou Tongchuang Medical Jiangsu Reable Medical Changzhou Resource Medical Jiangsu Kangjin Medical AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Edding
Published Date: Sep 2016
Published By: QYResearch

Price: $3900
Global Gastric Cancer Drugs Sales Market Report 2016
Sales, means the sales volume of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies sales (consumption) of Gastric Cancer Drugs in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, marke
Published Date: Sep 2016
Published By: QYResearch

Price: $4000
United States Gastric Cancer Drugs Market Report 2016
Sales, means the sales volume of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies sales (consumption) of Gastric Cancer Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rat
Published Date: Sep 2016
Published By: QYResearch

Price: $3800
Global Gastric Cancer Drugs Market Research Report 2016
Production, means the output of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies Gastric Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Hoffmann-La Roche Eli-lilly Sanofi Otsuka Holdings Novartis Amgen Boston Biomedical AROG Pharmaceuticals ARIAD Pharmaceuticals Roche Merck Eli Lilly AB Science Bayer HealthCare Boehringer Ingelheim Bristol-Myers Squibb Five Prime BIND Therapeutics Ipsen Biopharmaceuticals Eddingpharm Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth r
Published Date: Sep 2016
Published By: QYResearch

Price: $2900
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
?Gastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach and is the fifth-most common cancer globally. There are many types of gastric cancer, but adenocarcinoma is the most common type and is diagnosed in 95% of cases. The life expectancy and survival rate for gastric cancer is heavily dependent on the stage of the disease when diagnosed.
Published Date: Sep 2016
Published By: GBI Research

Price: $4995
United States Gastric Cancer Drug Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Gastric Cancer Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream ra
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
Global Gastric Cancer Drug Consumption 2016 Market Research Report
First, the report provides a basic overview of the Gastric Cancer Drug industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Gastric Cancer Drug market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Gastric Cancer Drug market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with informatio
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
Global Gastric Cancer Drug Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Gastric Cancer Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, produ
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Gastric Cancer Market Report: 2016 Edition
Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. 
Published Date: May 2016
Published By: Koncept Analytics

Price: $800
Gastric Cancer Global Clinical Trials Review, H1, 2016
Summary GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clini
Published Date: May 2016
Published By: GlobalData

Price: $2500
Global Gastric Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation o
Published Date: May 2016
Published By: Current Partnering

Price: $1495

Back To Top